Human Genome Sciences spurns GSK's $3B offer
April 19 2012
Human Genome Sciences rebuffed GlaxoSmithKline's advances Thursday with a press release that said, in essence, "Thanks for the $2.6 billion ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.